UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934.
For the quarterly period ended March 31, 2013
Commission File Number: 333-148471
NANOVIRICIDES, INC.
(Exact name of Company as specified in its charter)
NEVADA | 76-0674577 | |
(State or other jurisdiction) | (IRS Employer Identification No.) | |
of incorporation or organization) |
135 Wood Street, Suite 205
West Haven, Connecticut 06516
(Address of principal executive offices and zip code)
(203) 937-6137
( Company’s telephone number, including area code)
Indicate by check mark whether the Company (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the Company was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the Company has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Company was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the Company is a larger accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. (Check one)
Large accelerated filer | ¨ | Accelerated filer | ¨ |
Non-accelerated filer | x | Smaller reporting company | ¨ |
Indicate by check mark whether the Company is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
The number of shares outstanding of the Company's Common Stock as of May 15, 2013 was: 161,985,997
NANOVIRICIDES, INC.
(A DEVELOPMENT STAGE COMPANY)
March 31, 2013 and 2012
Index to the Financial Statements
Contents | Page(s) | |
Balance Sheets at March 31, 2013 (Unaudited) and June 30, 2012 | F-3 | |
Statements of Operations for the Three and Nine Months Ended March 31, 2013 and 2012 and for the Period from May 12, 2005 (Inception) through March 31, 2013 (Unaudited) | F-4 | |
Statements of Stockholders’ Equity for the Period from June 30, 2010 through March 31, 2013 (Unaudited) | F-5 | |
Statements of Cash Flows for the Nine Months Ended March 31, 2013 and 2012 and for the Period from May 12, 2005 (Inception) through March 31, 2013 (Unaudited) | F-6 | |
Notes to the Financial Statements (Unaudited) | F-7 |
F-2 |
Nanoviricides, Inc.
(A Development Stage Company)
Balance Sheets
March 31, 2013 | June 30, 2012 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
CURRENT ASSETS: | ||||||||
Cash and cash equivalents | $ | 15,457,807 | $ | 14,274,985 | ||||
Prepaid expenses | 541,634 | 314,174 | ||||||
Collateral advance for affiliate | 1,000,000 | - | ||||||
Total Current Assets | 16,999,441 | 14,589,159 | ||||||
PROPERTY AND EQUIPMENT | ||||||||
Property and equipment | 1,440,717 | 1,440,717 | ||||||
Accumulated depreciation | (984,033 | ) | (825,875 | ) | ||||
Property and equipment, net | 456,684 | 614,842 | ||||||
TRADEMARK | ||||||||
Trademark | 458,954 | 458,954 | ||||||
Accumulated amortization | (39,727 | ) | (33,147 | ) | ||||
Trademark, net | 419,227 | 425,807 | ||||||
Total Assets | $ | 17,875,352 | $ | 15,629,808 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
CURRENT LIABILITIES: | ||||||||
Accounts payable | $ | 237,661 | $ | 238,358 | ||||
Accounts payable – related parties | 630,385 | 365,681 | ||||||
Accrued expenses | 147,246 | 96,878 | ||||||
Derivative liability | 3,398,611 | 1,078,698 | ||||||
Total Current Liabilities | 4,413,903 | 1,779,615 | ||||||
LONG TERM LIABILITIES: | ||||||||
Debentures payable | 3,339,067 | - | ||||||
Total Long Term Liabilities | 3,339,067 | - | ||||||
Total Liabilities | 7,752,970 | 1,779,615 | ||||||
COMMITMENTS AND CONTINGENCIES | ||||||||
STOCKHOLDERS' EQUITY: | ||||||||
Series A Convertible Preferred stock, $0.001 par value, 10,000,000 shares designated, 10,465,000 and 9,871,250 shares issued and outstanding, respectively | 10,466 | 9,872 | ||||||
Series B Convertible Preferred stock, $0.001 par value, 10,000,000 shares designated, none issued and outstanding | - | - | ||||||
Series C Convertible Preferred stock, $0.001 par value, 10,000,000 shares
designated, 0 and 2,353 shares issued and outstanding, respectively | - | 2 | ||||||
Common stock, $0.001 par value; 300,000,000 shares authorized; 164,540,249 and 155,612,293 shares issued and outstanding, respectively | 164,571 | 155,645 | ||||||
Additional paid-in capital | 46,066,390 | 43,108,790 | ||||||
Deficit accumulated during the development stage | (36,119,045 | ) | (29,424,116 | ) | ||||
Total Stockholders' Equity | 10,122,382 | 13,850,193 | ||||||
Total Liabilities and Stockholders' Equity | $ | 17,875,352 | $ | 15,629,808 |
See accompanying notes to the financial statements
F-3 |
Nanoviricides, Inc.
(A Development Stage Company)
Statements of Operations
For the Period from | ||||||||||||||||||||
For the Three Months | For the Three Months | For the Nine Months | For the Nine Months | May 12, 2005 | ||||||||||||||||
Ended | Ended | Ended | Ended | (inception) through | ||||||||||||||||
March 31, 2013 | March 31, 2012 | March 31, 2013 | March 31, 2012 | March 31, 2013 | ||||||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||||||
OPERATING EXPENSES | ||||||||||||||||||||
Research and development | $ | 1,359,205 | $ | 1,582,705 | $ | 3,279,220 | $ | 3,252,745 | $ | 21,790,371 | ||||||||||
Refund credit research and development costs | - | - | - | - | (420,842 | ) | ||||||||||||||
General and administrative | 831,353 | 494,080 | 1,748,582 | 1,281,755 | 12,465,960 | |||||||||||||||
Total operating expenses | 2,190,558 | 2,076,785 | 5,027,802 | 4,534,500 | 33,835,489 | |||||||||||||||
LOSS FROM OPERATIONS | (2,190,558 | ) | (2,076,785 | ) | (5,027,802 | ) | (4,534,500 | ) | (33,835,489 | ) | ||||||||||
OTHER INCOME (EXPENSE): | ||||||||||||||||||||
Interest income (expense), net | (822,278 | ) | 30,801 | (770,825 | ) | 40,283 | (558,714 | ) | ||||||||||||
Discount on convertible debentures | - | - | - | - | (73,930 | ) | ||||||||||||||
Beneficial conversion feature of convertible debentures | - | - | - | - | (713,079 | ) | ||||||||||||||
Change in fair market value of derivatives | (669,753 | ) | 14,131 | (896,302 | ) | (68,931 | ) | (937,833 | ) | |||||||||||
Other income (expense), net | (1,492,031 | ) | 44,932 | (1,667,127 | ) | (28,648 | ) | (2,283,556 | ) | |||||||||||
LOSS BEFORE INCOME TAX PROVISION | (3,682,589 | ) | (2,031,853 | ) | (6,694,929 | ) | (4,563,148 | ) | (36,119,045 | ) | ||||||||||
INCOME TAX PROVISION | - | - | - | - | - | |||||||||||||||
NET LOSS | $ | (3,682,589 | ) | $ | (2,031,853 | ) | $ | (6,694,929 | ) | (4,563,148 | ) | $ | (36,119,045 | ) | ||||||
NET LOSS PER COMMON SHARE | ||||||||||||||||||||
- BASIC AND DILUTED: | $ | (0.02 | ) | $ | (0.01 | ) | $ | (0.04 | ) | (0.02 | ) | |||||||||
Weighted average common shares outstanding | ||||||||||||||||||||
- basic and diluted | 163,454,938 | 151,556,920 | 159,902,326 | 147,890,395 |
See accompanying notes to the financial statements
F-4 |
NanoViricides, Inc.
(A Development Stage Company)
Statement of Stockholders' Equity
For the period from June 30, 2010 through March 31, 2013
(Unaudited)
Deficit | ||||||||||||||||||||||||||||||||||||||||||||
Accumulated | ||||||||||||||||||||||||||||||||||||||||||||
Series A Preferred Stock: Par $0.001 | Series B Preferred Stock: Par $0.001 | Series C Preferred Stock: Par $0.001 | Common Stock: Par $0.001 | Additional | During the | Total | ||||||||||||||||||||||||||||||||||||||
Number of | Number of | Number of | Number of | Paid-in | Development | Stockholders' | ||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Capital | Stage | Equity | ||||||||||||||||||||||||||||||||||
Please refer to Form 10K for the fisacal year ended June 30, 2012 filed with SEC on October 15, 2012 for equity transactions occurred prior to June 30, 2009 | ||||||||||||||||||||||||||||||||||||||||||||
Balance, June 30, 2010 | 7,593,750 | $ | 7,594 | 260,000 | $ | 260 | - | $ | - | 133,980,471 | $ | 133,981 | $ | 23,116,612 | $ | (16,739,743 | ) | $ | 6,518,704 | |||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.51 per share, July 7, 2010 | 397,088 | 397 | 397 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, July 7, 2010 | (60,000 | ) | (60 | ) | (60 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, July 7, 2010 | (9,973 | ) | (9,973 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $1.65 per share, July 7, 2010 | 6,061 | 6 | 9,967 | 9,973 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, July 7, 2010 | 116,715 | 116,715 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.30 per share, July 21, 2010 | 463,177 | 463 | 463 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, July 21, 2010 | (60,000 | ) | (60 | ) | (60 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, July 21, 2010 | (7,671 | ) | (7,671 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $1.32 per share, July 21, 2010 | 5,794 | 6 | 7,665 | 7,671 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, July 21, 2010 | 113,700 | 113,700 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $2.087 per share, July 31, 2010 | 3,086 | 3 | 4,997 | 5,000 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.14 per share, August 4, 2010 | 526,916 | 527 | 527 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, August 4, 2010 | (60,000 | ) | (60 | ) | (60 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, August 4, 2010 | (5,370 | ) | (5,370 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP, at $1.14 per share, August 4, 2010 | 4,716 | 5 | 5,365 | 5,370 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, August 4, 2010 | 104,480 | 104,480 | ||||||||||||||||||||||||||||||||||||||||||
Warrants issued to Scientific Advisory Board, August 15, 2010 | 45,000 | 45,000 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued in conversion of Series B Preferred Shares at $0.99 per share, August 18, 2010 | 606,367 | 606 | 606 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, August 18, 2010 | (60,000 | ) | (60 | ) | (60 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, August 18, 2010 | (3,068 | ) | (3,068 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $0.99 per share, August 18, 2010 | 3,101 | 3 | 3,065 | 3,068 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, August 18, 2010 | 104,795 | 104,795 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $1.24 per share, August 31, 2010 | 4,032 | 4 | 4,996 | 5,000 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $0.93 per share, September 1, 2010 | 215,332 | 215 | 215 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, September 1, 2010 | (20,000 | ) | (20 | ) | (20 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, September 1, 2010 | (767 | ) | (767 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $1.00 per share, September 1, 2010 | 766 | 1 | 766 | 767 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, September 1, 2010 | 34,841 | 34,841 | ||||||||||||||||||||||||||||||||||||||||||
Series B Preferred Shares issued to SeaSide 88, LP, September 21, 2010 | 250,000 | 250 | 2,499,750 | 2,500,000 | ||||||||||||||||||||||||||||||||||||||||
Placement Agents fees related to sale of Convertible Preferred shares, September 21, 2010 | (195,000 | ) | (195,000 | ) | ||||||||||||||||||||||||||||||||||||||||
Legal fees related to sale of Convertible Preferred Stock, September 21, 2010 | (10,000 | ) | (10,000 | ) | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - issuance of Series B Preferred Shares | (328,086 | ) | (328,086 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $0.93 per share, September 21, 2010 | 430,015 | 430 | 430 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, September 21, 2010 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, September 21, 2010 | 103,012 | 103,012 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $1.07 per share, September 30, 2010 | 4,673 | 5 | 4,995 | 5,000 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $0.87 per share, October 5, 2010 | 460,346 | 460 | 460 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, October 5, 2010 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, on October 5, 2010 | (8,055 | ) | (8,055 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $0.87 per share, October 5, 2010 | 9,268 | 9 | 8,046 | 8,055 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - Retirement of Series B Preferred Shares, October 5, 2010 | 103,330 | 103,330 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $0.88 per share, October 19, 2010 | 452,965 | 453 | 453 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, October 19, 2010 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, October 19, 2010 | (6,521 | ) | (6,521 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $0.88 per share, October 19, 2010 | 7,384 | 7 | 6,514 | 6,521 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - Retirement of Series B Preferred Shares, October 19, 2010 | 69,635 | 69,635 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $1.03 per share, October 31, 2010 | 4,854 | 5 | 4,995 | 5,000 | ||||||||||||||||||||||||||||||||||||||||
Series A Preferred Shares issued for employee stock compensation, November 1, 2010 | 30,000 | 30 | 53,903 | 53,933 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $0.87 per share, November 2, 2010 | 461,313 | 461 | 461 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, August 4, 2010 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, November 2, 2010 | (4,986 | ) | (4,986 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $0.87 per share, November 2, 2010 | 5,751 | 6 | 4,980 | 4,986 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, November 2, 2010 | 69,104 | 69,104 | ||||||||||||||||||||||||||||||||||||||||||
Warrants issued to Scientific Advisory Board, November 15, 2010 | 55,800 | 55,800 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.16 per share, November 16, 2010 | 345,817 | 346 | 346 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, November 16, 2010 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, November 16, 2010 | (3,452 | ) | (3,452 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $1.16 per share, November 16, 2010 | 2,984 | 3 | 3,449 | 3,452 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - Retirement of Series B Preferred Shares, November 16, 2010 | 69,187 | 69,187 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.35 per share, November 30, 2010 | 310,566 | 311 | 311 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, November 30, 2010 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, November 30, 2010 | (1,918 | ) | (1,918 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $1.35 per share, November 30, 2010 | 1,417 | 1 | 1,917 | 1,918 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - Retirement of Series B Preferred Shares, November 30, 2010 | 69,449 | 69,449 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $1.46 per share, November 30, 2010 | 3,425 | 3 | 4,997 | 5,000 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of warrants to Common Stock at $1.00 per share, December 10, 2010 | 25,000 | 25 | 24,975 | 25,000 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as compensation pursuant to S-8 at $1.28 per share, December 10, 2010 | 50,000 | 50 | 63,950 | 64,000 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.10 per share, December 14, 2010 | 90,840 | 91 | 91 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, December 14, 2010 | (10,000 | ) | (10 | ) | (10 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, December 14 2010 | (384 | ) | (384 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as Dividend to Seaside 88, LP, at $1.10 per share, December 14, 2010 | 348 | - | 384 | 384 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, December 14, 2010 | 17,438 | 17,438 | ||||||||||||||||||||||||||||||||||||||||||
Series B Preferred Shares issued to SeaSide 88, LP, December 21, 2010 | 250,000 | 250 | 2,499,750 | 2,500,000 | ||||||||||||||||||||||||||||||||||||||||
Placement Agents fees related to sale of Convertible Preferred shares, December 21, 2010 | (200,000 | ) | (200,000 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $1.32 per share, December 31, 2010 | 4,545 | 5 | 5,995 | 6,000 | ||||||||||||||||||||||||||||||||||||||||
Adjustment | 33 | 33 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.16 per share, January 3, 2011 | 343,796 | 344 | 344 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, January 3, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, January 3, 2011 | (8,904 | ) | (8,904 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $1.16 per share, January 3, 2011 | 7,653 | 8 | 8,896 | 8,904 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, January 3, 2011 | 73,532 | 73,532 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.26 per share, January 17, 2011 | 317,965 | 318 | 318 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, January 17, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, January 17, 2011 | (8,055 | ) | (8,055 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $1.26 per share, January 17, 2011 | 6,403 | 6 | 8,049 | 8,055 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, January 17, 2011 | 70,882 | 70,882 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.12 per share, January 31, 2011 | 356,422 | 356 | 356 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, January 31, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, January 31, 2011 | (6,521 | ) | (6,521 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $1.24 per share, January 31, 2011 | 5,271 | 5 | 6,516 | 6,521 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement ofSeries B Preferred Shares, January 31, 2011 | 72,432 | 72,432 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $1.47 per share, January 31, 2011 | 4,087 | 4 | 5,996 | 6,000 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of warrants at $1.00 per share, February 4, 2011 | 25,000 | 25 | 24,975 | 25,000 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.08 per share, February 14, 2011 | 370,017 | 370 | 370 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, February 14, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, February 14, 2011 | (4,986 | ) | (4,986 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP, at $1.08 per share, February 14, 2011 | 4,613 | 5 | 4,981 | 4,986 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, February 14, 2011 | 71,699 | 71,699 | ||||||||||||||||||||||||||||||||||||||||||
Warrants issued to Scientific Advisory Board, Feburary 15, 2011 | 54,000 | 54,000 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $0.99 per share, February 28, 2011 | 405,610 | 406 | 406 | |||||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, February 28, 2011 | 71,490 | 71,490 | ||||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, February 28, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, February 28, 2011 | (3,452 | ) | (3,452 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $0.99 per shares, February 28, 2011 | 3,500 | 4 | 3,448 | 3,452 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $1.22 per share, February 28, 2011 | 4,902 | 5 | 5,995 | 6,000 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for employee stock compensation at $1.32 per share, March 3, 2011 | 250,000 | 250 | 316,000 | 316,250 | ||||||||||||||||||||||||||||||||||||||||
Series A Preferred Shares issued for employee stock compensation, March 3, 2011 | 593,750 | 594 | 1,364,036 | 1,364,630 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.09 per share, March 14, 2011 | 367,274 | 367 | 367 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, March 14, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, March 14, 2011 | (1,918 | ) | (1,918 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as Dividend to Seaside 88, LP at $1.09 per shares, March 14, 2011 | 1,761 | 2 | 1,916 | 1,918 | ||||||||||||||||||||||||||||||||||||||||
Derivative Liability - Retirement of Series B Preferred Shares, March 14, 2011 | 70,566 | 70,566 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.11 per share, March 28, 2011 | 89,986 | 90 | 90 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, March 28, 2011 | (10,000 | ) | (10 | ) | (10 | ) | ||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, March 28, 2011 | (384 | ) | (384 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP, at $1.11 per share, March 28, 2011 | 345 | - | 384 | 384 | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, March 28, 2011 | 17,525 | 17,525 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $1.28 per share, March 31, 2011 | 4,680 | 5 | 5,995 | 6,000 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of warrants to common stock at $1.00 per share, April 10, 2011 | 10,000 | 10 | 9,990 | 10,000 | ||||||||||||||||||||||||||||||||||||||||
Series B Preferred Shares issued to SeaSide 88, LP, April 18, 2011 | 250,000 | 250 | 2,499,750 | 2,500,000 | ||||||||||||||||||||||||||||||||||||||||
Placement Agents fees related to sale of Convertible Preferred shares, April 18, 2011 | (160,000 | ) | (160,000 | ) | ||||||||||||||||||||||||||||||||||||||||
Legal fees related to Sale of Convertible Preferred Stock, April 18, 2011 | (25,000 | ) | (25,000 | ) | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - issuance of Series B Preferred Shares | (429,725 | ) | (429,725 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.28 per share, April 18, 2011 | 312,163 | 312 | (272 | ) | 40 | |||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, April 18, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, April 18, 2011 | 68,756 | 68,756 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $1.47 per share, April 30, 2011 | 4,087 | 4 | 5,996 | 6,000 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.18 per share, May 2, 2011 | 339,726 | 340 | (300 | ) | 40 | |||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, May 2, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, May 2, 2011 | 68,941 | 68,941 | ||||||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, May 2, 2011 | (8,055 | ) | (8,055 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $1.18 per shares, May 2, 2011 | 6,841 | 7 | 8,048 | 8,055 | ||||||||||||||||||||||||||||||||||||||||
Warrants issued to Scientific Advisory Board, May 15, 2011 | 50,400 | 50,400 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.19 per share, May 16, 2011 | 336,501 | 337 | (297 | ) | 40 | |||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, May 16, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, May 16, 2011 | 69,194 | 69,194 | ||||||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, May 16, 2011 | (6,521 | ) | (6,521 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $1.20 per shares, May 16, 2011 | 5,438 | 5 | 6,516 | 6,521 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.23 per share, May 30, 2011 | 326,480 | 326 | (286 | ) | 40 | |||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, May 30, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, May 30, 2011 | 69,464 | 69,464 | ||||||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, May 30, 2011 | (4,986 | ) | (4,986 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as Dividend to Seaside 88, LP at $1.23 per share, May 30, 2011 | 4,070 | 4 | 4,982 | 4,986 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $1.47 per share, May 31, 2011 | 4,087 | 4 | 5,996 | 6,000 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.18 per share, June 13, 2011 | 339,971 | 340 | (300 | ) | 40 | |||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, June 13, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, June 13, 2011 | 69,727 | 69,727 | ||||||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, June 13, 2011 | (3,452 | ) | (3,452 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as Dividend to Seaside 88, LP at $1.18 per share, June 13, 2011 | 2,934 | 3 | 3,449 | 3,452 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.02 per share, June 27, 2011 | 391,850 | 392 | (352 | ) | 40 | |||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, June 27, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative Liability - Retirement of Series B Preferred Share, June 27, 2011 | 69,973 | 69,973 | ||||||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, June 27, 2011 | (1,918 | ) | (1,918 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as Dividend to Seaside 88, LP at $1.10 per share, June 27, 2011 | 1,741 | 2 | 1,916 | 1,918 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $1.22 per share, June 30, 2011 | 4,902 | 5 | 5,995 | 6,000 | ||||||||||||||||||||||||||||||||||||||||
Net loss | (6,477,165 | ) | (6,477,165 | ) | ||||||||||||||||||||||||||||||||||||||||
Balance, June 30, 2011 | 8,217,500 | 8,218 | 10,000 | 10 | - | - | 143,548,494 | 143,582 | 33,235,990 | (23,216,908 | ) | 10,170,891 | ||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $1.11 per share, July 11, 2011 | 89,986 | 90 | 90 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, July 11, 2011 | (10,000 | ) | (10 | ) | (10 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, July 11, 2011 | 17,881 | 17,881 | ||||||||||||||||||||||||||||||||||||||||||
Dividend to Seaside 88, LP, paid on July 11, 2011 | (381 | ) | (381 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as dividend to Seaside 88, LP at $1.18 per share, July 11, 2011 | 345 | - | 381 | 381 | ||||||||||||||||||||||||||||||||||||||||
Series B Preferred Shares issued to SeaSide 88, LP, on July 26, 2011 | 250,000 | 250 | 2,499,750 | 2,500,000 | ||||||||||||||||||||||||||||||||||||||||
Placement Agents fees related to sale of Convertible Preferred shares, July 26, 2011 | (150,000 | ) | (150,000 | ) | ||||||||||||||||||||||||||||||||||||||||
Derivative liability - issuance of Series B Preferred Shares | (429,768 | ) | (429,768 | ) | ||||||||||||||||||||||||||||||||||||||||
Legal Fees related to Sale of Convertible Preferred Stock, July 26, 2011 | (6,250 | ) | (6,250 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued in conversion of Series B Preferred Shares to common stock at $1.18 per share, July 26, 2011 | 377,800 | 378 | 378 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, July 26, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, July 26, 2011 | 68,425 | 68,425 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $1.26 per share, July 31, 2011 | 4,762 | 5 | 5,995 | 6,000 | ||||||||||||||||||||||||||||||||||||||||
Warrants issued to Scientific Advisory Board, August 15, 2011 | 56,400 | 56,400 | ||||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $0.92 per share, August 8, 2011 | 437,187 | 437 | 437 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, August 8, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, August 8, 2011 | 69,193 | 69,193 | ||||||||||||||||||||||||||||||||||||||||||
Dividend to Seaside 88, LP, paid on August 8, 2011 | (8,055 | ) | (8,055 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as Dividend to Seaside 88, LP at $0.98 per share, August 8, 2011 | 8,205 | 8 | 8,047 | 8,055 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $0.95 per share, August 23, 2011 | 419,829 | 420 | 420 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, August 23, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, August 23, 2011 | 69,351 | 69,351 | ||||||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, August 23, 2011 | (6,521 | ) | (6,521 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as Dividend to Seaside 88, LP at $0.95 per share, August 23, 2011 | 6,844 | 7 | 6,514 | 6,521 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $1.14 per share, August 31, 2011 | 5,263 | 5 | 5,995 | 6,000 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for conversion of Series B Preferred Shares at $0.95 per share, September 6, 2011 | 422,873 | 423 | 423 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, September 6, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Shares, September 6, 2011 | 69,887 | 69,887 | ||||||||||||||||||||||||||||||||||||||||||
Dividend paid to Seaside 88, LP, September 6, 2011 | (4,986 | ) | (4,986 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as Dividend to Seaside 88, LP at $0.95 per share, September 6, 2011 | 5,264 | 5 | 4,981 | 4,986 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued in conversion of Series B Preferred Shares at $0.94 per share, September 19, 2011 | 427,652 | 428 | 428 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, September 19, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative liability - retirement of Series B Preferred Share, September 19, 2011 | 69,970 | 69,970 | ||||||||||||||||||||||||||||||||||||||||||
Dividend to Seaside 88, LP, paid on September 19, 2011 | (3,452 | ) | (3,452 | ) | ||||||||||||||||||||||||||||||||||||||||
Common shares issued as Dividend to Seaside 88, LP at $0.94 per share, September 19, 2011 | 3,691 | 3 | 3,449 | 3,452 | ||||||||||||||||||||||||||||||||||||||||
Common shares issued for consulting and legal services valued at $1.07 per share, September 30, 2011 | 5,607 | 6 | 5,994 | 6,000 | ||||||||||||||||||||||||||||||||||||||||
Shares issued in conversion of Series B Preferred Shares to Common Stock at $.78 per share, .001 par value, on October 3, 2011 | 514,311 | 514 | 514 | |||||||||||||||||||||||||||||||||||||||||
Retirement of Series B Preferred Shares converted into common stock by SeaSide 88, LP, .001 par value on October 3, 2011 | (40,000 | ) | (40 | ) | (40 | ) | ||||||||||||||||||||||||||||||||||||||
Derivative Liability - Retirement of Preferred Series B on October 3, 2011 | 69,496 | 69,496 | ||||||||||||||||||||||||||||||||||||||||||
Shares issued as Dividend to Seaside 88, LP, .001 par value common stock at $0.85 on October 3, 2011 |